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To identify molecular effects of the antineoplastic agent protein
kinase C inhibitor 412 (PKC412) (midostaurin), we applied gene
expression profiling in zebrafish using whole-genome microarrays.
Behavioral, developmental, and physiological effects were in-
vestigated in order to analyze for correlations between altered
gene expression profiles with effects on development and
physiology. Zebrafish blastula-stage embryos were exposed for 6
days postfertilization to nominal levels of 2 and 40 mg/l PKC412.
Among the 259 and 511 altered transcripts at both concentrations,
respectively, the expressions of genes involved in the circadian
rhythm were further investigated. Alteration of swimming
behavior was not observed. Pathways of interest affected by
PKC412 were angiogenesis, apoptosis, DNA damage response,
and response to oxidative stress. Angiogenesis was analyzed
in double-transgenic zebrafish embryos Tg(fli1a:EGFP)
y1;Tg(gata1:dsRed)sd2; no major defects were induced by
PKC412 treatment at both concentrations. Apoptosis occurred
in olfactory placodes of embryos exposed to 40 mg/l, and DNA
damage was induced at both PKC412 concentrations. However,
there were no significant effects on reactive oxygen species
formation. This study leads to the conclusion that PKC412-
induced alterations of gene transcripts are partly paralleled by
physiological effects at high, but not at low PKC412 concen-
trations expected to be of environmental relevance.
Key Words: PKC412; Danio rerio; transgenic zebrafish;
microarray; angiogenesis; apoptosis.
Antineoplastic agents have widespread use in cancer treatment.
They include different classes, such as antibodies, protein kinase
inhibitors (such as protein kinase C inhibitor 412 [PKC412]),
topoisomerase I and II inhibitors, antimetabolites, alkylating
agents, and others (Chabner et al., 2006). Antineoplastic agents
are mainly found in the nanograms per liter to the lower
micrograms per liter range in effluents (Fent et al., 2006;
Monteiro and Boxall, 2010). For example, ifosfamide was found
in Germany up to a concentration of 2.9 lg/l (Ternes, 1998).
As many pharmacological targets are evolutionary conserved,
antineoplastic agents are supposed to have similar effects in
aquatic organisms as in humans (Christen et al., 2010;
Gunnarsson et al., 2008; Jones et al., 2007) Therefore,
environmental exposure may pose a risk for negative effects
on nontarget species because of the mutagenic and cancero-
genic properties of such compounds.
A newly developed antineoplastic agent is midostaurin
(PKC412, logKOW ¼ 4.26; Novartis Pharma AG, Basel,
Switzerland; internal data), which belongs to the family of
indolocarbazoles and is a selective inhibitor of several isoforms of
protein kinase C in humans (Karaman et al., 2008). It is a sugar
ring variant of staurosporine, which was originally isolated from
Streptomyces staurosporeus (Takahashi et al., 1989). PKC412
inhibits a large variety of tyrosine kinases including FMS-like
tyrosine kinase (FLT3), platelet-derived growth factor (PDGF)
receptors, and c-kit (stem cell factor) receptor (Fabbro et al.,
2000). PKC412 has been developed as a therapeutic agent
against acute myeloid leukemia because of its ability to inhibit
growth, angiogenesis, and P-glycoprotein–mediated multidrug
resistance in tumor cells (Fabbro et al., 2000). In addition,
PKC412 affects other cellular processes such as immune
responses or neuronal functions, as shown by effective inhibition
of human T-cell activation, proliferation, and tumor necrosis
factor alpha production (Si et al., 2005).
Only very few data are available on the toxicity of PKC412
to organisms that may be exposed via wastewater. Exposure of
zebrafish blastula-stage embryos to 100nM (57 lg/l) PKC412
resulted in a curved body axis (Chan et al., 2002). Recent data
indicate that the no observed effect concentration (NOEC) of
PKC412 was 14 lg/l in a Danio rerio early life–stage test and
the lowest observed effect concentration for mortality was
43 lg/l. The 96-h LC50 in adult D. rerio was 25 lg/l and the
NOEC 19 lg/l (Novartis Pharma AG, internal data). The
estimated predicted environmental concentration is 1.5 lg/l
(Novartis Pharma AG, internal data).
 The Author 2010. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved.
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Currently, there is a lack of chronic toxicity studies with
focus on the modes of action on this pharmaceutical in
vertebrates and invertebrates. Furthermore, ecological risk
assessments of PKC412 within the framework of the European
Medicines Agency (2006), in particular at environmentally
realistic concentrations in aquatic organisms, are not publicly
available. Ecotoxicological tests used for risk assessments are
often not sensitive enough to identify subtle adverse effects of
pharmaceuticals. They may be more accurately determined by
focusing on the modes of action (Christen et al., 2010; Fent
et al., 2006; Runnalls et al., 2007). Therefore, potential
environmental consequences of PKC412 are unknown. In de-
tail, data on the gene expression profile and their correlation
to environmentally relevant endpoints such as behavior and
mortality are missing.
In our present study, we aim at determining the modes of
action of this novel antineoplastic agent in zebrafish embryos to
clarify its potential molecular effects by analyzing the global
gene expression pattern. The toxicogenomics approach allows
to identify several thousands of genes and the corresponding
expression profiles upon exposure, which will assist in the
elucidation of the molecular effects and the compound’s modes
of action (Robbens et al., 2007). We analyze effects at low
concentrations in zebrafish embryos and compare the effects
on the transcriptional level with effects on mortality and
physiological outcomes. We hypothesize that the response
of zebrafish to PKC412 exposure is similar to the human
response, as their targets, the protein kinases, are evolutionary
conserved. Therefore, we searched for alterations in gene
expression patterns associated with cellular signaling (e.g.,
angiogenesis and apoptosis) and oxidative stress. We also
hypothesized that alterations in gene expression—because of
multiple endpoints and mechanistic information—are more
sensitive than physiological or morphological parameters
(although they are perhaps less ecologically relevant) but that
the observed molecular effects correlate with and propagate to
higher levels of the biological organization. In addition, gene
expression analysis may also reveal unknown regulatory
mechanisms in fish not directly related to the modes of action
of PKC412 in humans.
MATERIALS AND METHODS
Chemicals
PKC412 ( 99%, molecular weight: 570.6, logKOW ¼ 4.26) was kindly
provided by Novartis Pharma AG. Acetonitrile was purchased from
Brunschwig (Basel, Switzerland) and methanol was from Stehelin (Basel,
Switzerland). Ammonium formiate, dimethyl sulfoxide (DMSO), formic acid,
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), MgCl2, NaCl,
sucrose, Triton X-100, H2O2, 4#,6-diamidino-2-phenylindole (DAPI), and
dichlorofluorescein-diacetate (DCFH-DA) were obtained from Sigma-Aldrich
(Buchs, Switzerland). 4-2-Aminoethyl-benzensulfonyl fluoride hydrochloride
(AEBSF), EDTA, low melting agarose, and Tris-HCl were purchased from
AppliChem.GmbH (Darmstadt, Germany). Roti-Histofix (10%) was purchased
from Carl Roth GmbH & Co. KG (Karlsruhe, Germany). PBS was obtained
from F. Hoffmann-La Roche Ltd (Basel, Switzerland).
Exposure Experiment
For the microarray, behavioral, and toxicity studies, freshly fertilized zebrafish
embryos were obtained from Harlan Laboratories Ltd (Itingen, Switzerland).
Embryos were transferred to the laboratory and examined under a stereomicro-
scope. All embryos used in the experiments were at blastula stage (Kimmel et al.,
1995). They were placed in 750-ml covered glass beakers of reconstituted water
(total hardness of 125 mg/l as CaCO3 and a conductivity of 270 lS/cm) and the
appropriate concentration of PKC412 or DMSO (0.01%, solvent control). The
water temperature was held constant at 27C ± 1C with the photoperiod set at
16:8 h light/dark.
The semistatic exposure setup consisted of six replicates of water control,
solvent control (0.01% DMSO), and two PKC412 doses. A total of 100
fertilized eggs per replicate (n ¼ 6) were exposed up to 6 days postfertilization
(dpf) to nominal concentrations of 2 and 40 lg/l PKC412, respectively. This
exposure duration seemed to be appropriate as lethal effects occurred already
after 3 dpf in the early life stages test. Every 24 h, lethal and sublethal effects
were evaluated, dead embryos or eleuthero-embryos were removed, and the
water was changed. The quality of the exposure water was continuously moni-
tored by oxygen concentration determination (> 70%), the pH value (6.7–7.2),
and the temperature (27C ± 1C). At the end of exposure, eleuthero-embryos
were anesthetized in a clove oil solution (Fluka AG, Buchs, Switzerland). A
total of 80 eleuthero-embryos per replicate were pooled in RNAlater for
microarray and quantitative real time polymerase chain reaction (qRT-PCR).
Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Basel,
Switzerland).
Chemical Analysis
To determine actual exposure concentrations, 10-ml aliquots of exposure
water were taken during the experiment for PKC412 analysis. Water samples of
each treatment group were taken at the beginning (0 h) and prior to full water
renewal (24 h). This was done three times on different days from different
randomly selected replicate tanks. Acetonitrile (2 ml) was added to the water
samples for liquid chromatography-mass spectrometry (LC-MS) analysis
preparation and then stored at 20C until analysis. The chemical analysis
was performed separately for the microarray experiment, the behavioral
experiment, and additional experiments (terminal deoxynucleotidyl transferase
dUTP nick end labeling [TUNEL] assay, comet assay and reactive oxygen
species [ROS] assay).
PKC412 concentrations were determined by LC-MS. The chromatographic
separation was achieved by using an Inertsil ODS-3 column (2.1 3 50 mm;
3 lm particle size) from Ercatech AG (Bern, Switzerland) at a column
temperature of 30C. For the analysis, a binary gradient mixture containing
eluent A (0.1% [vol/vol] in formic acid in water:acetonitrile [95:5]) and eluent B
(0.1% [vol/vol] in formic acid in water:acetonitrile [5:95]) was used at a flow rate
of 0.4 ml/min. The gradient started with a mixture of 60% eluent A and 40%
eluent B and increased to 100% eluent B after 4 min. The conditions were held
for 1 min, and then the system was set back to the initial conditions. The column
was reequilibrated for 2 min before the next injection. Five microliters of the
samples were injected. The retention time for PKC412 was 3.3 min. Data were
then quantified using DataAnalysis for 6300 Series Ion Trap LC/MC version 3.4.
Quantification of PKC412 was based on an external calibration curve.
RNA Isolation, Array Hybridization, and Sample Selection
Total RNA was extracted from zebrafish eleuthero-embryos using the
RNeasy Mini Kit (Qiagen). Total RNA concentrations were measured
spectrophotometrically using a NanoDrop ND-1000 UV-VIS Spectrophotom-
eter at 260 nm. The integrity of each RNA sample was verified using an Agilent
2100 Bioanalyzer (Agilent Technologies, Basel, Switzerland). Only samples
containing a 260/280 nm ratio between 1.8 and 2.1, a 28S/18S ratio between
1.5 and 2, and an RNA integrity number > 8 were processed further. A total of
16 arrays (Agilent 4 3 44 K Zebrafish Microarray) were used, including four
for the water control group, four for the solvent control group, four for the
2 lg/l, and four for the 40-lg/l PKC412 dose group. Total RNA samples
(600 ng) were reverse transcribed into double-strand complementary DNA
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(cDNA) in the presence of RNA poly-A controls with the Agilent One-Color
RNA Spike-In Kit. Cyanine 3 (Cy3) labeling and hybridization were performed
according to the manufacturer’s manual.
After reverse transcription of RNA into double-stranded cDNA, double-
strand cDNA was in vitro transcribed into complementary RNA (cRNA) in the
presence of Cy3-labeled nucleotides using a Low RNA Input Linear Amp
Kit þCy dye (Agilent Technologies), performed at the Functional Genomic
Center (ETHZ and University of Zu¨rich, Switzerland). The Cy3-labeled cRNA
was purified using an RNeasy Mini Kit (Qiagen), and quality and quantity was
determined using a NanoDrop ND-1000 UV-VIS Spectrophotometer and an
Agilent 2100 Bioanalyzer, respectively. Only cRNA samples with a total cRNA
yield higher than 2 lg and a dye incorporation rate between 9 and 20 pmol/lg
were used for hybridization. Cy3-labeled cRNA samples (1.65 lg) were mixed
with Agilent blocking solution, subsequently fragmented randomly to 100–200
bp at 65C with fragmentation buffer, and resuspended in hybridization buffer
as provided by the Gene Expression Hybridization Kit (Agilent Technologies).
Target cRNA samples (100 ll) were hybridized to the Agilent Zebrafish 43 44
K Gene Expression Microarray for 17 h at 65C. The hybridized arrays were
then washed using Agilent GE wash buffers 1 and 2 according to the manu-
facturer’s instructions and scanned by an Agilent Microarray Scanner (Agilent
p/n G2565BA) at 5-lm resolution with the green photomultiplier tube set to
100% and a scan area of 61 3 21.6 mm. Image generation and feature
extraction were performed using the Agilent Feature Extraction (FE) software
version 9.5.3. Quality control was additionally considered before performing
the statistical analysis. These included array hybridization pattern inspection:
absence of scratches, bubbles, areas of nonhybridization, proper grid alignment,
spike performance in controls with a linear dynamic range of five orders of
magnitude, and the number of green-feature nonuniformity outliers, which
should be below 100 for all samples.
qRT-PCR Analysis
One microgram of total RNA of the microarray experiment template was
reverse transcribed using Moloney murine leukemia virus reverse transcriptase
(Promega Biosciences Inc., Wallisellen, Switzerland) in the presence of
random hexamers (Roche Diagnostics) and deoxynucleoside triphosphate
(Sigma-Aldrich). The reaction mixture was incubated for 5 min at 70C and
then for 1 h at 37C. The reaction was stopped by heating at 95C for 5 min.
The cDNA was used to perform SYBR-PCR based on SYBR-Green
Fluorescence (FastStart Universal SYBR Green Master, Roche Diagnostics).
Eight differentially expressed genes of interest (ATP-binding cassette,
subfamily C [abcc4], cryptochrome 5 [cry5], N-myc downstream–regulated
gene 1, like [ndrg1l], opsin 1 [cone pigments], medium wave–sensitive, 2
[opn1mw2], 3-phosphoinositide-dependent protein kinase-1 [pdpk1], period
homolog 1 [per1], similar to son of sevenless homolog 2 [sos], and xeroderma
pigmentosum, complementation group C [xpc]) were selected for confirmation
of microarray results using qRT-PCR. Gene-specific primers were designed
based on published zebrafish sequences (Table 1).
The following PCR reaction profile was used: one cycle at 95C for 10 min
followed by 40 cycles at 95C for 15 s and 59C for 60 s followed by a melting
curve analysis after run.
The delta threshold cycle (CT) value was derived by subtracting the CT
value for the housekeeping gene ribosomal protein L13 a (RpL13a), which
served as an internal control, from the CT value of the target gene, respectively.
All reactions were run in duplicate using the Biorad CFX96 RealTime PCR
Detection System (Biorad, Reinach, Switzerland). The messenger RNA
expression level of the different genes was expressed as fold increase
according to the formula:
2DCTðuntreated sampleÞ DCTðtreated sampleÞ
Measurement of Locomotor Activity
Multispecies Freshwater Biomonitor. Effects of PKC412 on locomotor
activity were measured in zebrafish eleuthero-embryos. Their locomotor
activity was observed using a flow-through test chamber with quadrupole
impedance conversion as measuring device, connected to a measuring unit and
personal computer with data analysis software (Gerhardt et al., 1994).
Measurement chambers, made of an acryl glass cylinder sealable on both
ends, with a size of 4 cm in length and a diameter of 2 cm allowed free
movement of the eleuthero-embryos during measurement.
For locomotor activity measurements, embryos in the blastula stage were
exposed to 2.1 and 31 lg/l PKC412, respectively, for 6 dpf as described above.
Locomotor activities of hatched eleuthero-embryos were assessed 6 dpf for 20
animals per PKC412 dose and the appropriate controls, respectively, as
described above. Following an acclimation phase of 10 min, measurements
TABLE 1
Primer Sequences for Quantitative Real-Time PCR Analysis
Probe ID Gene Sequence accession # Direction Sequence Amplicon size (bp)
— RpL13a fw agc tca aga tgg caa cac 100
rv ag aag ttc ttc tcg tcc tcc
A_15_P104624 abcc4 NM_001007038 fw ctg gaa aca cga ctc agc aa 122
rv gct cac cag agc att gaa ca
A_15_P103946 cry5 NM_131788.1 fw cat gga gag aac gaa ctg gg 115
rv gtg cag aca agc agc cga ac
A_15_P196411 ndrg1l NM_200692.1 fw agc gtc ttt gag ctg gac at 113
rv tgg aag gtc agg atg gta gg
A_15_P544897 opn1mw2 NM_182891.2 fw cca tgg cag ttt aag gca ct 100
rv ttt tgt gct gag ctg tga cc
A_15_P112731 pdpk1 NM_001077344.1 fw cgt tta gag ctg gga acg ag 103
rv cgc tgg acc aga tct tta gc
A_15_P236266 per1 NM_001030183.1 fw atg cgt gca aga agt ggt g 131
rv acg tcc tca ttt agc gga ctc
A_15_P197856 sos XM_685079.2 fw ctg ccc tca ctt ctc acc tc 109
rv cac tgg tcc aca cca aac ac
A_15_P134231 xpc NM_001045210.1 fw aag aag tcg gca gtg agg aa 101
rv gca tat ttt cac ggc tcc at
106 OGGIER ET AL.
were started and behavior was monitored with a recording duration lasting 4
min for a period of 2 h with intervals of 10 min each. For locomotor activity
measurements, means of locomotor activities (percent time spent on
locomotion) for each individual were calculated for 2-h time period.
Angiogenesis
Double-transgenic zebrafish embryos (Tg(fli1a:EGFP)y1;Tg(gata1:dsRed)
sd2) (Lawson and Weinstein, 2002; Traver et al., 2003) were exposed to 2 and
40 lg/l PKC412 and held in water and DMSO control water (50 embryos each)
for 6dpf as described above. Embryos were monitored for morphological
defects using a fluorescent binocular at 24 hours postfertilization (hpf), 48 hpf,
and 6dpf. Formation of blood vessels was observed with transgenic expression
of enhanced green fluorescent protein in endothelial cells and red fluorescent
protein from Discosoma sp. expression in blood cells. Transgenic fish were
kept heterozygotic; therefore, only half of the progeny is double transgenic and
these were analyzed in detail. Representative embryos taken from treated and
control groups were imaged using a Leica TCS SP5 Confocal Microscopy
System.
Apoptosis Assay
Apoptotic cells of eleuthero-embryos were determined by the TUNEL assay.
Eleuthero-embryos were exposed 6 dpf as described above. Embryos exposed
to 1% H2O2 served as a positive control. After 6 dpf, the eleuthero-embryos
were fixed in 4% Roti-Histofix at 4C for 24 h. Thereafter, the embryos were
rehydrated through a series of methanol (100, 90, 70, and 50%). The TUNEL
assay (Roche ‘‘In situ Cell Death Detection Kit, TMR red’’) was performed
as described in the manufacturer’s manual. In brief, single eleuthero-embryos
(n ¼ 3 per replicate) were permeabilized in PBS containing 0.1% Triton X-100
for 8 min. Thereafter, they were washed twice with PBS and then labeled for
60 min at 37C. The embryos were then embedded in agarose and analyzed
under the fluorescent microscope at excitation and emission wavelength of
360–370 and 420 nm, respectively.
Alkaline Comet Assay
This assay allows detecting DNA breakages induced by genotoxic agents.
The comet assay was performed as described (Duong et al., 2010). Briefly,
embryos were exposed to PKC412 as described above for 6 dpf. As a positive
control, embryos were exposed to 1% H2O2 for 10 min prior to anestization.
A pool of eight eleuthero-embryos per replicate (n ¼ 4) was macerated in 1 ml
PBS containing 20mM EDTA for 5 min. The supernatant was removed, and the
embryos were shred in 500 ll PBS containing 20mM EDTA for 10 min. The
remaining tissue was sedimented for 2 min, and the supernatant was embedded
in agarose on a microscope slide. Cells were then lysed at 4C for 1 h with lysis
buffer (2.5M NaCl, 0.1M EDTA, 10mM Tris-HCl, pH 10, 1% Triton X-100)
and electrophoresed for 5 min at 25 V. Damaged DNA fragments migrate faster
in the electric field than intact DNA, which can be visualized after staining with
DAPI. Cells (24 cells per replicate) were observed under the fluorescence
microscope, and the length of comets, percent DNA in tail, tail moment,
and olive tail moment were calculated using CometScore 1.5 (TriTek,
Sumerduck, VA).
ROS Measurements
In this assay, the nonfluorescent probe DCFH-DA is oxidized into the highly
fluorescent 2,7-dichlorofluorescein in the presence of ROS. ROS measurements
were conducted according to Deng et al. (2009). In brief, eight pre-exposed
eleuthero-embryos (pre-exposure for 6 dpf as described for the microarray
experiment) were washed with cold PBS and then homogenized in cold lysis
buffer containing 0.32mM sucrose, 20mM HEPES, 1mM MgCl2, and 0.5mM
AEBSF, pH 7.4. As a positive control, eight eleuthero-embryos were exposed
for 10 min to water containing 1% H2O2. Thereafter, the homogenate was
centrifuged at 15,000 3 g at 4C for 20 min, and the supernatant was
discharged. The pellet was then resuspended in PBS, and 20 ll were added to
a 96-well plate and incubated for 5 min at room temperature. Thereafter, 100 ll
of PBS and 8.3 ll of DCFH-DA (stock solution in DMSO, 10 mg/ml) were
added to each well. The plate was incubated at 37C for 30 min, and
fluorescence measurements were made with excitation at 485 nm and emission
at 530 nm, respectively.
Data Analysis and Statistics
Raw microarray data were analyzed using the GeneSpring GX 10 software
(Agilent Technologies). In a first step, the Agilent FE software output was
filtered on the basis of feature saturation, nonuniformity, pixel population
consistency, and signal strength relative to background level (Agilent FE
Manual). Only positively marked entities were accepted for further evaluation.
All data were quantile normalized. In a second step, several quality control
steps (e.g., correlation plots and correlation coefficients, quality metric plots,
and principal components analysis) using the quality control tool of
GeneSpring were performed to ensure that the data were of good quality.
Differentially expressed genes from the microarray were determined using
a Benjamini-Hochberg multiple correction ANOVA test (p < 0.05) followed by
a Tukey honestly significant difference technique post hoc test. The genes
were considered differentially expressed when p < 0.05 and the fold change
(FC)  2. To determine gene ontology (GO) categories of differentially ex-
pressed genes, the GO analysis tool in GeneGo, San Diego, CA, was used.
Only those categories where p < 0.05 were considered differentially altered.
MetaCore (GeneGo) was used to identify and visualize the involvement
of the differentially expressed genes in specific pathways (false discovery
rate [FDR] < 0.05). The microarray data used in this analysis have been submitted
to the National Center for Biotechnology Information Gene Expression Omnibus
database under accession number GSE23156 (http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?token¼fnotryskkqyaoba&acc¼GSE23156).
Data from microarray analysis, qRT-PCR, locomotor activity, comet assay,
and ROS assay were illustrated graphically with GraphPad Prism 5 (GraphPad
Software, San Diego, CA). Data distribution for normality was assessed with
the Kolmogorov-Smirnov test and the variance homogeneity with the Bartlett
test. Differences between treatments were assessed by ANOVA followed by
a Tukey test (Bartelett test p < 0.05) to compare treatment means with
respective controls. If the data were not normally distributed, differences
between treatments were assessed by the Kruskal-Wallis test followed by
Dunn’s multiple comparison test. Results are given as mean ± SEM.
Differences were considered significant at p  0.05.
RESULTS
PKC412 Concentrations and Embryo Survival
PKC412 concentrations in the exposure water were measured
at 0 and 24 h in order to determine the actual exposure
concentrations. The PKC412 concentrations measured indepen-
dently in the different experiments are given in Table 2. In the
microarray experiment, actual concentrations were lower than
nominal, and they decreased during exposure. Geometric mean
concentrations (n ¼ 3) were 1.3 and 21 lg/l. Also in the
behavioral experiment using the Multispecies Freshwater
Biomonitor (MFB), the PKC412 concentration decreased during
the 24-h exposure and the mean measured concentration was 2.1
and 31 lg/l. In the experiments where the comet assay, TUNEL
assay, and ROS assay were performed, the initial concentrations
were close to nominal and decreased again during the 24-h
exposure. The mean measured concentrations were 1.6 and
31 lg/l. No significant mortality was observed in any of the
different experiments and treatment groups.
Alteration of Gene Expression
Gene expression profiles derived from microarray results of
control and PKC412-exposed embryos (n ¼ 4) are based on 80
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pooled individuals. As listed in Supplementary table S1, 259
and 511 genes were differentially expressed in zebrafish
eleuthero-embryos (log2  2, p < 0.05) after exposure to 1.3
and 21 lg/l PKC412, respectively. At 1.3 lg/l PKC412, 112
(43%) genes were downregulated and 147 (57%) upregulated.
Of the 511 genes differentially expressed at 21 lg/l PKC412,
130 (25%) genes were downregulated and 381 (75%) were
upregulated. Only 101 of the significantly altered genes
were regulated at both concentrations; however, all of them
were regulated in the same direction. At both concentrations,
most functional groups of genes (FC, log2 at least twofold,
p  0.05) were similar. GO analysis was performed to identify
functional groups of genes. GO defines terms representing gene
product properties and covers three domains, namely, cellular
components, molecular functions, and biological processes. At
both concentrations, functionally identified genes fell into more
than 1500 different categories. In Supplementary table S2, the
top 100 GO processes are listed. GO categories including all
kind of different detections or responses to stimuli are of
particular importance, e.g., detection of light stimulus, detection
of abiotic stimulus, detection/response to external stimulus,
visual perception, etc. (Supplementary table S2).
In addition to the GO analysis, we performed a pathway
analysis with MetaCore. The different treatments had 28 maps
(1.3 lg/l PKC412: 29 maps; 21 lg/l PKC412: 34 maps) with
their corresponding pathways in common (Supplementary table
S3). These maps include pathways for lipid biosynthesis and
regulation, cholesterol and bile acid homeostasis, angiogenesis,
vitamin and cofactor metabolism and its regulation, mitogenic
signaling, and apoptosis. For validation of these results, addi-
tional experiments were performed focusing on five significantly
altered maps (Table 3). Effects on angiogenesis were analyzed
by performing an additional experiment with transgenic zebra-
fish. In addition, effects on apoptosis were analyzed by perfor-
ming a TUNEL assay, DNA damage was assessed by a comet
assay, and oxidative stress response by a ROS assay.
In order to confirm the microarray results, qRT-PCR was
performed for eight selected genes (Table 3, Fig. 1). These genes
belong to different pathways and were selected on their
importance in different pathways: abcc4, cry5, ndrg1l, opn1mw2,
pdpk1 1, per1, sos, and xpc. A downregulation occurred for
abcc4, cry5, per1, and xpc, whereas an upregulation was found
for ndrg1l, opn1mw2, pdpk, and sos (Fig. 1, Table 3). In all
cases, except sos, the same tendency for up- or downregulation
occurred for the microarray and for qRT-PCR analysis.
Effects on the Circadian Rhythm and Locomotor Activity
As shown in Supplementary table S1, PKC412 altered the
expression of genes regulating circadian rhythm, e.g., cry1-5
(1.3 lg/l PKC412: 2.08, 3.9, 4.4, 2.3, 2.7 FC log2,
respectively; 21 lg/l PKC: 1.54, 2.7, 3, 1.8, 2.9 FC log2,
respectively), per1,2,4 (1.3 lg/l PKC412:9.8,2.04,4.5 FC
log2, respectively; 21 lg/l PKC: 6.4, 3.08, 3.17 FC log2,
respectively), arntl (1.3 lg/l PKC412: 2.5 FC log2; 21 lg/l PKC:
3.12 FC log2), clock (1.3 lg/l PKC412: 2.9 FC log2; 21 lg/l
PKC: 2.7 FC log2), etc. In mammals, the circadian rhythm
controls a diversity of behavioral and physiological rhythmic
processes such as regulation of sleep wakefulness, secretion of
hormones, and locomotor activity (Hastings, 1997). In zebrafish,
diazepam alters the same set of genes and influences the
swimming behavior (Oggier et al., 2010). Therefore, an
additional set of experiments was performed to evaluate whether
changes found in the gene expression pattern of circadian genes
TABLE 3
FCs of Selected Genes Differentially Regulated in Zebrafish
Eleuthero-Embryos Determined by Microarray and qRT-PCR
after Exposure to 1.3 and 21 mg/l PKC412. Values Are
Expressed as Average FC. Asterisks Show Statistically
Significant Difference to Control (p < 0.05)
FC (log2)
Gene name
1.3 lg/l PKC412 21 lg/l PKC412
Array qPCR Array qPCR
abcc4 2.00* 1.21* 2.98* 1.03*
cry5 2.68* 2.35* 2.86* 2.12*
ndrg1l 4.00* 1.99* 4.10* 2.41*
opn1mw2 2.60* 0.45* 2.36* 1.00*
pdpk1 2.60* 0.88* 1.71* 1.05*
per1 9.80* 3.58* 6.41* 3.16*
sos 0.85* 0.27 2.03* 0.62
xpc 2.90* 1.40* 2.20* 0.55
TABLE 2
Nominal and Measured Concentrations of PKC412 in Exposure
Waters after 6 dpf of Exposure for the Microarray, Multispecies
Freshwater Biomonitor Experiment and Comet Assay
Nominal
concentration
Exposure waters
Measured concentration (lg/l)
0 h % Nominal 24 h % Nominal
Geometric
mean
Microarray
2 lg/l 1.50 ± 0.1 75.2 1.06 ± 0.2 52.9 1.3
40 lg/l 25.12 ± 1.6 62.8 17.20 ± 3.1 43.0 21
Multispecies Freshwater
Biomonitor
2 lg/l 2.36 ± 0.1 117.8 1.90 ± 0.2 95.1 2.1
40 lg/l 37.45 ± 1.7 93.6 25.10 ± 1.7 62.7 31
TUNEL assay, comet
assay, and ROS assay
2 lg/l 2.19 ± 0.2 109.5 1.23 ± 0.1 61.7 1.6
40 lg/l 38.60 ± 6.4 96.5 24.93 ± 5.2 62.3 31
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in eleuthero-embryos were paralleled by changes in the
locomotor activity. The behavioral experiments revealed that
exposure of the embryos to PKC412 did not significantly affect
their locomotor activity (Supplementary fig. S1).
Effects on Angiogenesis
Angiogenesis is an important process during cancerogenesis,
which is affected by PKC412 in humans (Fabbro et al., 2000).
We hypothesized that similar effects occur in zebrafish
embryos during development. Important genes in angiogenesis
are the vascular endothelial growth factor (vegf), which is
downregulated by PKC412 in humans (Fabbro et al., 2000),
and angiopoietin (ang). In our study, we did not find a signi-
ficant alteration in vegf transcript levels in zebrafish eleuthero-
embryo (data not shown). However, there is a significant
upregulation of ang2 (3.6 FC log2) in the higher PKC412
concentration of 31 lg/l (Supplementary table S1). Ang2 is an
antagonist of ang1 and disrupts blood vessel formation when
overexpressed (Maisonpierre et al., 1997). In addition to
alterations in gene expression, we also found a significant
alteration of pathways involved in vascular development
(Table 4).
In order to link these findings with physiological changes in
blood vessel development, we exposed (Tg(fli1a:EGF-
P)y1;Tg(gata1:dsRed)sd2) double-transgenic zebrafish em-
bryos to 2 and 40 lg/l PKC412. Although focusing mostly
on the trunk vasculature, we did not observe any abnormalities
in cardiovascular development compared with control em-
bryos. At 24 hpf, the dorsal aorta and the posterior cardinal
vein developed normally and normal sprouting of the inter-
segmental vessels was observed. At 6 dpf, all the main vessels
looked virtually identical in treated and control embryos (Fig. 2).
Dorsal aorta, posterior cardinal vein, and intersegmental vessels
were normally developed, and normal heart beat and blood flow
was observed.
Twenty-five double-transgenic embryos from each treatment
were analyzed in detail. We also looked at general morphology
of the embryos. Single embryos from treated and control groups
showed mild developmental abnormalities, which can occasion-
ally be observed in nontreated fish, especially in transgenic lines.
Five of 25 embryos treated with 40 lg/l PKC412 had a slightly
misshaped trunk with the tail bend dorsally. However, the
vasculature of these embryos was normal (Fig. 2). More analyses
on wild-type embryos would be needed to find out whether this
misshaping is because of the drug treatment.
Therefore, PKC412 did not negatively interfere up to 6 days
with the vascular development of zebrafish embryos at both
concentrations. However, the vascular network at this stage is
already very complicated and subtle differences might have
been gone unnoticed.
Effects on Apoptosis in Olfactory Placodes
PKC inhibitors can induce apoptosis in humans (Tenzer et al.,
2001). Thereby, the phosphatidylinositol 3#-kinase (PI3K3)/
Akt pathway is of high importance as the cytotoxic effect of
PKC412 is mediated by this pathway. In the apoptosis pathway,
the phosphoinositide-dependent kinase (PDK) 1 (also called
PDPK1) leads to phosphorylation of v-akt murine thymoma viral
oncogene homolog Akt and therefore to its activation. Con-
stitutively active Akt results in an enhanced protection against
apoptotic cellular insults. In contrast to findings in humans, we
found an upregulation of pdpk (Supplementary table S1, 2.6 FC
log2) in the lower PKC412 concentration.
In addition, we found a downregulation of transcripts of
xpc, a gene that is important for DNA damage recognition.
Additionally, apoptotic pathways are of significance (Table 4).
Based on these findings, we conducted a TUNEL assay to search
for regions and tissue in the eleuthero-embryo where apoptosis is
induced by PKC412. Supplementary figure S2 illustrates that
apoptosis mostly occurred in the head region. The olfactory
placode, which is important for the perception of odorants, is
mainly affected. This finding is in parallel to the observed
upregulation of gene transcripts of some odorant receptors
or102-3 (2.8 FC log2) and or11-10 (2.2 FC log2) found by
microarray analysis for the highest PKC412 concentration
(Supplementary table S1), suggesting a repair of these affected
cells.
TABLE 4
Four Maps and Pathways to Which Additional Experiments
Were Performed Represented in MetaCore (FDR < 0.05)
Map Pathway p Value
Vascular
development
(angiogenesis)
Transcription_Role of Akt in
hypoxia-induced HIF1 activation
3.414 3 102
Transcription_Receptor-mediated
HIF regulation
Development_FGFR signaling pathway
Apoptosis Transcription_P53 signaling pathway 5.423 3 102
Development_Flt3 signaling
Apoptosis and survival_Role of
CDK5 in neuronal death and
survival
Apoptosis and survival_BAD
phosphorylation
Apoptosis and survival_Antiapoptotic
action of gastrin
Apoptosis and survival_HTR1A signaling
DNA damage
response
Transcription_P53 signaling pathway 1.146 3 101
DNA damage_Role of Brca1
and Brca2 in DNA repair
DNA damage_Brca1 as a
transcription regulator
DNA damage_Nucleotide
excision repair
Apoptosis and survival_BAD
phosphorylation
Oxidative stress
regulation
Development_Dopamine D2
receptor transactivation of EGFR
4.140 3 101
Note. EGFR: epidermal growth factor receptor.
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FIG. 1 Comparison of gene expression in zebrafish larvae determined by microarray (n ¼ 4 replicates, 80 eleuthero-embryos pooled, white bars) and
qRT-PCR (n ¼ 6, 80 eleuthero-embryos, black bars) after exposure to 1.3 and 21 lg/l PKC412, respectively. Values are expressed as average FC (log2) with SE
compared with control animals as indicated for selected genes. Asterisks (*) indicate statistically significant difference to control (p < 0.05).
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Effects on DNA Damage
PKC412 led to significant downregulation of xpc. At 1.6 and
31 lg/l PKC412, we found a 2.9 and 2.2 FC log2, respectively,
in xpc transcripts (Table 3, Fig. 1). Additionally, there was
a downregulation of apex nuclease 1 (2.7 FC log2) at 31 lg/l
PKC412. As xpc is important in DNA damage recognition and
APEX1 for DNA repair, we conducted a comet assay to
evaluate whether this alteration occurs not only on the
transcription but also on the physiological level. Further
support for potential DNA damage induced by PKC412 comes
from the fact that pathways involved in DNA damage response
were significantly affected (Table 4). The comet assay
demonstrates a dose-dependent increase in DNA damage in
eleuthero-embryos exposed to PKC412 (Fig. 3). Significant
DNA damage occurred in the embryos at 31 lg/l PKC412. At
the lower concentration of 1.6 lg/l PKC412, a significant
increase in tail length, but not in percent DNA in tail, tail
moment, and olive tail moment, occurred (Fig. 3).
Effects on Formation of ROS
MetaCore pathway analysis indicated that there is an
alteration in oxidative stress regulation. To evaluate whether
this is related to increased formation of ROS by PKC412, we
performed an additional experiment to determine formation
of ROS. The results show that the ROS levels remained
unchanged at both PKC412 concentrations as compared with
the control (Supplementary fig. S3), and thus PKC412 is not
inducing ROS.
DISCUSSION
This is the first study investigating the effects of PKC412 on
gene expression on nontarget organisms in aquatic systems.
We show effects of PKC412 at low concentrations in zebrafish
eleuthero-embryos. Thereby, we demonstrate that this human
pharmaceutical exhibits its effects in aquatic organisms by
similar molecular modes of action as in humans because of
target conservation in vertebrates (Christen et al., 2010
Gunnarsson et al., 2008). We also tested the hypothesis that
alteration in gene expression propagates into physiological
effects.
PKC412 was designed as tyrosine kinase inhibitor with
a broad inhibition spectrum of the human kinome. It was
shown that at high-affinity interactions (Kd < 100nM), this
compound was not highly selective for kinases (Karaman et al.,
2008). Consequently, it is not surprising that PKC412 alters
more than 500 genes in zebrafish eleuthero-embryos at
a concentration of 21 lg/l. Furthermore, the broad spectrum
of kinases inhibited by the nonselective PKC412 makes the
interpretation of the results challenging because of the
involvement of many cellular pathways.
In humans, PKC412 inhibits FLT3, PDGF receptors, VEGF,
and c-kit by preventing the tyrosine autophosphorylation
(Fabbro et al., 2000). In addition, this compound inhibits
P-glycoprotein–mediated multidrug resistance in tumor cells.
When comparing our results with human effects and gene
expression changes obtained in MV4-11 cells (human
lymphoblast cells) after treatment with 570 lg/l PKC412
(Stolzel et al., 2010), some similarities show up. In zebrafish
eleuthero-embryos, there were also alterations of solute carriers
as in human cells (Stolzel et al., 2010), albeit a solute carrier of
family 2 was significantly downregulated in the lower
concentration only. In addition, we similarly found a significant
downregulation of the ABC transporter abcc4, which is
important for the efflux of anticancer drugs. However, there
was no alteration of flt3, pdgfr, vegf, and c-kit at the transcript
level in zebrafish embryos. Binding of PKC412 leads to
inhibition of these kinases; therefore, we hypothesize that
PKC412 does not interfere with gene expression but protein
function. One important identified GO category is visual
FIG. 2 Vascular development is not affected by PKC412 treatment. The vascular system was visualized in a double-transgenic zebrafish eleuthero-embryo
(TG:fli1a:EGFPy1; gata1:DsRedsd2) on a Leica TCS SP5 Confocal Microscope. Endothelial cells are labeled in green and erythrocytes are labeled in red.
(A) DMSO solvent control and (B) 40 lg/l PKC412. The pictures are maximal intensity projections of confocal z-stacks. DA, dorsal aorta; PCV, posterior cardinal
vein; ISV, intersomitic vessel; DLAV, dorsal longitudinal anastomotic vessel. No major defects were detected in treated PKC412 embryos.
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perception. Expression of genes encoding proteins involved
in vision such as crystallins and opsins were significantly
altered by PKC412. Crystallins are important for the
protection against lens opacity (Clark, 2004), and opsins
are important for dim-/daylight vision and color vision
(Takechi and Kawamura, 2005). These findings in zebrafish
are similar to results obtained in mice and humans after
treatment with PKC412. There are several VEGF and PDGF
receptors in the retina. The inhibition of these receptors can
lead to decreased epiretinal membrane formation in mice
(Saishin et al., 2003) and reduction in macular edema in
humans (Campochiaro, 2004). Therefore, upregulation of
crystallins and opsins may be a response to the inhibition of
VEGF and PDGF receptors.
In addition to visual perception, we also found that responses
to light and external/internal stimuli are important targets of
PKC412. As the circadian rhythm is dependent on stimuli,
namely, Zeitgeber, there is a significant alteration of those
genes at both PKC412 concentrations in zebrafish. It is known
that in mice, several protein kinases C are expressed in the
hypothalamic suprachiasmattic nuclei (SCN) (Van der Zee and
Bult, 1995), the region which is important for circadian
processes. Therefore, protein kinases C play an important role
in the mammalian circadian rhythm, and inhibition of PKC can
lead to phase advances (Jakubcakova et al., 2007; Schak and
Harrington, 1999). As PKC is already expressed in the early
zebrafish development (Patten et al., 2007; Slatter et al., 2005),
it could be affected in the SCN. Additionally, it was shown in
the marine dinoflagellate Lingulodinium polyedrum that
staurosporine (precursor of PKC412) leads to phase shifting
and it increases the free running period of the circadian rhythm
(Comolli and Hastings, 1999). At the behavioral level, altered
expression of clock genes is correlated with changes in the
locomotor activity (Jakubcakova et al., 2007). For this reason,
we investigated the effects of PKC412 on the locomotor
activity. However, PKC412 had no significant effect on the
locomotor activity in our experimental setup. A reason could
be that an observation over 2 h is too short to obtain significant
effects. Also the time point when the measurements took
place could have an influence. We performed our measure-
ments at daylight, and effects would have probably been more
pronounced at night.
FIG. 3 Comet assay in zebrafish eleuthero-embryos exposed to 1.6 and 31 lg/l PKC412. (A) Tail length, (B) percent DNA in Tail, (C) Tail Moment, and (D)
Olive Tail Moment were calculated using CometScore. Four slides per dosage were examined, and 24 cells per slide were scored. The values are presented as the
mean ± SEM. Asterisks (*) indicate values that are significantly different from the control (Kruskall-Wallis test followed by post hoc Dunn’s multiple comparison
test; p < 0.05).
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In addition to exploring effects on different GO categories,
we performed a pathway analysis in order to elucidate altered
maps and pathways after PKC412 exposure. Out of the 28
maps, we chose four different maps with their corresponding
pathways to perform additional experiments. It is known from
humans that PKC412 can have effects on angiogenesis and
apoptosis including DNA damage repair. However, there are
no indications from mammalian studies that PKC412 exposure
can lead to the formation of ROS.
The need for new blood vessels is important during
embryogenesis, as well as in processes during cancerogenesis
(Carmeliet and Jain, 2000). The formation of blood vessels
and evaluation of blood flow can be observed in zebrafish
eleuthero-embryos, rendering it an ideal model organism to
study angiogenesis. As angiogenesis is affected by PKC412 in
humans (Fabbro et al., 2000), we hypothesize that similar
effects occur in zebrafish eleuthero-embryos. Thereby, angio-
poietins play an important role (Kubota et al., 2005; Pham
et al., 2001). In fact, we found a significant upregulation of
ang2. It was shown that overexpression of ang2 can lead to
blood vessel disruption in the mouse embryo (Maisonpierre
et al., 1997). There is also a simultaneous regulation of VEGF
and angiopoietin. However, angiopoietins do not participate
in the initial vascular phase of vascular development but rather
play an important role in angiogenic outgrowth, vessel re-
modeling, and maturation (Dumont et al., 1994; Suri et al.,
1996). Our results obtained after the exposure of double-
transgenic zebrafish eleuthero-embryos support the findings
that angiopoietins do not participate in the initial vascular
phase. In addition, our findings are in agreement with those
obtained after exposure of zebrafish eleuthero-embryos to
57 lg/l for 24 hpf (Chan et al., 2002). PKC412 did not generate
measurable antiangiogenic effects during the exposure time. It
may be possible that there are strain differences between
zebrafish that account for our failure to detect vascular defects
in transgenic fish. However, our results are in line with the
microarray data in the sense that we did not find any alteration
in vegf transcript levels. In addition, the defects in the vas-
culature might be too subtle to detect upon PKC412 treatment,
so that they went unnoticed in our assays.
PKC inhibitors can induce apoptosis in humans (Tenzer
et al., 2001). To protect mammals from apoptotic stress stimuli,
the PI3K/Akt survival pathway is important. In this pathway,
Akt needs to be phosphorylated by the PDK1, which was found
to be downregulated in mice after treatment with staurosporine
(Hill et al., 2001). In mice, PKC412 can mediate its cytotoxic
effects partly via downregulation of this pathway. Additionally,
PKC412 decreased the site-specific phosphorylation of Akt
required for its activity (Tenzer et al., 2001). In contrast to
these findings, we found an upregulation of the upstream
pdpk1 at the lower PKC412 concentration. This leads to the
hypothesis that there is no downregulation of the Akt pathway
but a protection against apoptosis. However, there is the
indication that the failure in DNA damage recognition
(downregulation of xpc) is more important, and therefore,
apoptosis is induced in limited regions of the eleuthero-
embryo. The TUNEL assay showed that apoptotic cells were
located in the olfactory placodes (fig. S2). As there is also an
upregulation of odorant receptors, which are mainly expressed
in the olfactory placodes, we suggest that this is a reaction to the
damage and associated to repairing the loss of cells. Yet, there is
no evidence for this phenomenon in mammals.
DNA damage can be paralleled with apoptosis. To evaluate
whether alterations in xpc and apex can be linked to DNA
damage, we performed comet assays. There is a clear link
between gene expression alteration and DNA damage at both
PKC412 concentrations. Although there is not significantly
more DNA in the tail, there is a significant increase in tail
length indicating that DNA damage took place. Data from the
comet assay demonstrate that gene expression changes in DNA
damage recognition are paralleled with intracellular DNA
damage. These data are in agreement with the results obtained
in human lymphoblast cells after treatment with PKC412
(Seedhouse et al., 2006).
We also showed that physiological outcomes of maps of low
significance, as the regulation of oxidative stress, do not
correlate with the obtained gene expression. Nevertheless,
several markers such as metallothionein (mt, 2.3-fold down-
regulated at 21 lg/l) and glutathione S-transferase M (gstm,
1.1- and 1.2-fold downregulated at 1.3 and 21 lg/l,
respectively) were significantly altered. It is known that mt is
upregulated by free radicals in rainbow trout cells (Kling and
Olsson, 2000). Our findings on the alteration of gst are in
contrast with those obtained in goldfish after treatment with
gemfibrozil, which is supposed to downregulate the antioxidant
defense system (Mimeault et al., 2006). However, the gene
expression of other markers such as the superoxide dismutase
(sod) or the catalase (cat) was not altered.
In our study, we demonstrate that the response of zebrafish
eleuthero-embryo to different PKC412 concentrations is partly
similar to the response in humans. Significant changes in gene
expression occurred at low concentrations of 1.3 lg/l PKC412.
This demonstrates that alterations in gene expression are more
sensitive than mortality and physiological effects. Additionally,
the gene expression profile points to the modes of action
of PKC412 in zebrafish. Because of the very broad kinase
inhibition spectrum of PKC412, a correlation to physiological
alterations is difficult. In some cases, gene expression changes
were not paralleled by physiological changes at low concen-
trations and sometimes even at high concentrations. This raises
the question whether and when gene expression changes
propagate to toxicological relevant measures such as reduction
of the ability to find food, to reproduce, or to escape from
predators.
In conclusion, the present study confirms that the toxicoge-
nomic approach provides important data to identify and char-
acterize molecular effects and to investigate potential modes of
action of an antineoplastic agent. This allows for establishing
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new biomarkers, not regularly assessed in routine ecotoxico-
logical studies. PKC412-induced alterations of gene transcripts
were partly paralleled by physiological effects at high, but not
at low, PKC412 concentrations that may be of environmental
relevance. Our study also shows that molecular studies should
be paralleled with ecotoxicological investigations of known
ecological relevance to interrelate sensitive changes in gene
expression to physiological effects.
SUPPLEMENTARY DATA
Supplementary data are available online at http://toxsci.
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